DriverMap™ EXP Human Genome-wide 19K Profiling Kit, V3
Product Description
The DriverMap™ EXP Human Genome-wide 19K Profiling Kit (hGW19K) measures the expression level of almost 19,000 human protein-coding genes by combining highly multiplexed RT-PCR amplification with the depth and precision of Next-Generation Sequencing (NGS) quantitation. It is an easy-to-run, single-tube, single-day assay that can be run directly from total RNA isolated from cells, tissue, or blood, or directly from cellular extract using the DirectCell™ Protocol.
The development of the DriverMap™ EXP hGW19K Assay involved extensive optimization and experimental validation of tens of thousands of primer sets to identify a pool of primers that could be combined in a single multiplex RT-PCR reaction to amplify representative transcript sequences (i.e., conserved transcript regions common to different mRNA isoforms from the same gene) from each of ~19,000 protein-coding genes in the human genome.
The amplified sequences are quantified using NGS on the Illumina platform. The DriverMap™ EXP hGW19K Assay provides optimal quantitative expression data within a 104 – 105-fold dynamic range from 10-50 ng of total RNA and can be used effectively with as little as 1 ng of RNA.
- An easy-to-run, one-tube, single-day assay allows profiling of transcripts from total RNA isolated from whole blood, PBMC, tissue, or directly from a small number (e.g., 100-50,000) of purified cells without prior RNA isolation
- The assay provides robust, quantitative, and reproducible measurements of the copy number of mRNAs over as many as 4-orders of magnitude differences in expression level
- The assay provides increased sensitivity from a small amount of RNA (1-50 ng) using a set of highly experimentally-validated primers
- The DriverMap EXP protocol employs several mechanisms to minimize amplification of off-target and primer dimer background products
- No mRNA enrichment, rRNA, mitochondrial, beta-globin depletion, or other total RNA processing is required
- The primers are designed using Illumina’s DNA/RNA dual UD Indexes labeling strategy to minimize NGS index-swapping background issues, and amplified products are compatible with 100-150-cycle Paired-End NGS sequencing using Illumina’s NextSeq/NovaSeq instruments
- NGS data can be analyzed using the Salmon software package available online. Cellecta also provides custom data analysis services on request. Please contact us
Gene List
Gene List DriverMap™ EXP Human Genome-wide 19K Profiling Kit, V3
How It Works
Gene-specific primers (GSPs) initiate first strand synthesis. As a result, gene-specific first-strand cDNA templates are synthesized in the RT reaction. The RNA is removed after the RT reaction, and as a consequence, the reaction has much less background.
Product Citations
- Garcia P et al. (2024) Liver cancer in ovo models for preclinical testing. The FASEB Journal
- Kumarasamy V et al. (2024) The Extracellular Niche and Tumor Microenvironment Enhance KRAS Inhibitor Efficacy in Pancreatic Cancer. Cancer Res (2024) 84 (7): 1115–1132.
- Wu J et al. (2024) Separable Cell Cycle Arrest and Immune Response Elicited through Pharmacological CDK4/6 and MEK Inhibition in RASmut Disease Models. Mol Cancer Ther 3;23(12):1801-1814.
- Catalog Number
DM3-HGW-24-CT - Supplier
Cellecta - Size
- Shipping
Blue Ice